Short Interest in Bavarian Nordic A/S (OTCMKTS:BVNRY) Grows By 109.8%

Bavarian Nordic A/S (OTCMKTS:BVNRY) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 8,600 shares, a growth of 109.8% from the December 15th total of 4,100 shares. Based on an average trading volume of 27,900 shares, the days-to-cover ratio is currently 0.3 days.

Bavarian Nordic A/S Stock Down 3.9 %

Shares of OTCMKTS BVNRY traded down $0.36 during midday trading on Wednesday, hitting $8.84. The stock had a trading volume of 4,917 shares, compared to its average volume of 9,402. Bavarian Nordic A/S has a 1-year low of $6.86 and a 1-year high of $14.60. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 12.81 and a beta of 1.65. The company has a fifty day moving average price of $9.06 and a 200 day moving average price of $10.10.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.